Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-03-29
1995-10-10
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3140
Patent
active
054571200
ABSTRACT:
The present invention provides a method of inhibiting gastric acid secretion in mammals by administering a 5-HT1A agonist compound or a pharmaceutically acceptable salt thereof.
REFERENCES:
patent: 4576959 (1986-03-01), Flaugh
patent: 4745126 (1988-05-01), Leander
patent: 5204340 (1993-04-01), Flaugh et al.
patent: 5229409 (1993-07-01), Flaugh et al.
Handbook of Experimental Pharmacology, vol. XIX "5-Hydroxytrofptanine and Related Indolealkylanines", Erspaner, v. sub-ed, Springer-Verlog, New York, 1966, pp. 329-335.
Gidda Jaswant S.
Schaus John M.
Demeter John C.
Eli Lilly and Company
Henley III Raymond
Weddington K.
LandOfFree
Method of inhibiting gastric acid secretion with 4- amino-1, 3, does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of inhibiting gastric acid secretion with 4- amino-1, 3, , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of inhibiting gastric acid secretion with 4- amino-1, 3, will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2310655